Previous close | 38.98 |
Open | 39.06 |
Bid | 0.00 x 1800 |
Ask | 0.00 x 800 |
Day's range | 38.78 - 39.55 |
52-week range | 25.82 - 42.24 |
Volume | |
Avg. volume | 1,036,259 |
Market cap | 3.513B |
Beta (5Y monthly) | 1.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.00 (5.13%) |
Ex-dividend date | 03 May 2024 |
1y target est | N/A |
NEW YORK, May 09, 2024--Lazard, Inc. (NYSE: LAZ) today announced Michele Colocci is joining the firm on 3rd June 2024 as Vice Chairman, Investment Banking and Managing Director, Healthcare. Based in London, Mr. Colocci’s appointment accelerates the growth of Lazard’s best-in-class global healthcare franchise, led by David Gluckman, and further reinforces its leading position in Europe, which is headed by Jean-Louis Girodolle and Cyrus Kapadia.
NEW YORK, April 25, 2024--Lazard, Inc. (NYSE: LAZ) today reported net revenue of $765 million and adjusted net revenue1 of $747 million for the quarter ended March 31, 2024. On a U.S. GAAP basis, first-quarter 2024 net income was $36 million or $0.35 per share, diluted. Adjusted net income2 was $67 million, or $0.66 per share, diluted, for the quarter.
NEW YORK, April 24, 2024--Lazard, Inc. (NYSE: LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on May 17, 2024, to stockholders of record on May 6, 2024.